2 min read
FLUXION BIOSCIENCES EXPANDS ADVANCED THERAPEUTICS DISCOVERY SERVICES UNIT
Relocation and expansion to support high customer demand globally
October 5, 2022, Alameda, CA: Fluxion Biosciences, a privately held drug discovery and diagnostic tools and services company, announced today that it is expanding its Advanced Therapeutics Discovery Services business unit to support growing demand for assay support of the company’s unique cell analysis platforms. Growth will be supported by increasing lab staff and relocating to a new, larger laboratory. Fluxion offers a range...